Preclinical trials of five
coronavirus vaccines started in Italy on Monday.
They are all being carried out by the biotech firm Takis,
results are expected by mid-May and human trials could start in
the autumn, CEO Luigi Aurisicchio told ANSA.
The vaccines are based on various regions of the protein
Spike, the main weapon with which the virus attacks human
respiratory cells.
ALL RIGHTS RESERVED © Copyright ANSA